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ABSTRACT. In the current state of art of drug dependence treatment programs,
psychopathological features seem to be associated with negative therapeutic outcome.
Drug abuse and especially drug dependence are complex disorders that include cognitive,
behavioral and physiologic signs and symptoms. The wide spectrum of symptoms that
characterize these disorders are responsible for clinical heterogeneity in terms of clinical
presentation, severity, vulnerability, sequelae, and comorbidity which by itself accounts
for great suffering and need for help in several areas. Assessment of both drug abuse
and psychological distress constitutes a major challenge for professionals working with
drug addicts. In the present descriptive study we tried to explore some key characteristics
of individuals with a drug addiction when starting a treatment program. A total of 107
participants visiting a large metropolitan Portuguese addiction treatment center participated
in this study, 90.7% were male, aged between 22 and 55 years (M = 34.84, SD = 6.44).
The results indicate the existence of some relationships between severity of drug addiction
and psychopathological symptoms.
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RESUMEN. En el contexto de la situación actual de los programas de tratamiento de
las toxiocodependencias, las características psicopatológicas parecen estar asociadas
con resultados terapéuticos negativos. El abuso de drogas, en especial la dependencia,
es una perturbación compleja que incluye síntomas cognitivos, comportamentales y
fisiológicos. El amplio espectro de síntomas que caracterizan estas perturbaciones es
responsable de su heterogeneidad clínica en términos de manifestación clínica, severi-
dad, vulnerabilidad, secuelas y comorbilidad que por sí solo implica un elevado sufri-
miento y necesidad de intervención en diferentes áreas. La evolución de la
toxicodependencia y de la psicopatología se constituye como un gran desafío para los
profesionales que trabajan en estos contextos. El presente estudio descriptivo trata de
explorar algunas características principales de los individuos con problemas de
toxicodependencia que iniciaron un programa de tratamiento. Participaron en el estudio
107 sujetos, con edades comprendidas entre 22 y 55 años (M = 34,84; DT = 6,44), que
frecuentan un centro metropolitano de tratamiento de las toxicodependencias, 90,7% de
los cuales pertenecen al sexo masculino. Los resultados señalan la presencia de algunas
relaciones entre la severidad del consumo y la sintomatología psicopatológica.
PALABRAS CLAVE. Toxicodependencia. Centro de tratamiento. Psicopatología. Es-
tudio descriptivo mediante encuestas.
RESUMO. No contexto do actual estado da arte dos programas de tratamento de
toxicodependências, as características psicopatológicas parecem estar associadas com
resultados terapêuticos negativos. O abuso de drogas, mas especialmente a dependência
são perturbações complexas que incluem sintomas e sinais cognitivos, comportamentais
e fisiológicos. O amplo espectro de sintomas que caracterizam estas perturbações é
responsáveis pela sua heterogeneidade clínica em termos da sua manifestação clínica,
severidade, vulnerabilidade, sequelas e comorbilidade que só por si implica um elevado
sofrimento e necessidade de intervenção em várias áreas. A avaliação da toxicodependência
e da psicopatologia constitui-se como um grande desafio para os profissionais que
trabalham nesses contextos. O presente estudo descritivo procura explorar algumas
características centrais dos indivíduos com problemas de toxicodependência que iniciaram
um programa de tratamento. Participaram neste estudo 107 sujeitos, com idades
compreendidas entre 22 e os 55 anos (M = 34,84; DP = 6,44), que frequentam um
centro metropolitano de tratamento de toxicodependências, 90,7% dos quais são do
sexo masculino. Os resultados indicam a existência de algumas relações entre a severidade
do consume e a sintomatologia psicopatológica.
PALAVRAS CHAVE. Toxicodependência. Centro de tratamento. Sicopatología. Estudo
descritivo mediante inquéritos.
Introduction
Drug abuse and dependence has become a major public health problem in Western
European countries (Gómez-Fragela, Luengo-Martín, Romero-Triñanes, Villar-Torres,
and Sobral-Fernández, 2006). People with a drug addiction present increased mortality
rates and exhibit a considerable variety of acute and chronic medical conditions, including
MACHADO and KLEIN. Drug dependence and distress en Portuguese patients 85
Int J Clin Health Psychol, Vol. 7, Nº 1
dependence symptoms, infectious diseases, and drug-related accidents and disabilities
(see Frischer et al., 1993). Unemployment or homelessness, disruption of family structure,
and criminal activities are also highly associated with drug addiction. In addition high
rates of comorbidity between substance use disorders and other mental disorders have
been shown both in several epidemiological and clinical samples (Appleby, Dyson,
Altman, and Luchins, 1997; Drake and Brunette, 1998; Lambert et al., 1996; Landa,
Fernández-Montalvo, López-Goñi, and Lorea, 2006). Nearly 70% of opiate users have
concurrent psychiatric diagnosis or exhibit some psychiatric symptomatology (Kebler,
1995). Similarly, findings of the Epidemiologic Catchment Area (Regier et al., 1990)
study, based on a sample of 20,291 individuals drawn from the community at large
indicate that more than half of those who met the medical criteria for diagnosis as drug
abusers also suffered from one or more mental disorders at some point during their
lifetime. This included 28% with anxiety disorders, 26% with mood disorders (e.g.,
depression), 18% with antisocial personality disorder, and 7% with schizophrenia. Some
had multiple disorders. The prevalence of mental disorders varied with the drug being
abused, ranging from 50% of marijuana abusers to 76% of those who abused cocaine.
Almost half of the drug abusers also suffered from alcohol abuse at some point during
their lifetime.
Drug abuse and specially drug dependence are complex disorders that include
cognitive, behavioral and physiologic signs and symptoms. They are characterized by
clinical heterogeneity in terms of clinical presentation, severity, vulnerability, sequelae,
and comorbidity which by itself accounts for great suffering and need for help in
several areas (Ziedonis and D’Avanzo, 1998). This heterogeneity increases the difficulty
in establishing the etiology of these multifaceted disorders, apply suitable treatments,
and predict treatment outcome over time. All these issues are crucial for drug abuse
and/or dependence treatment centers, which in their search for the highest treatment
efficacy are often confronted with a host of biopsychosocial needs far beyond drug use
itself. Therefore, treatment centers are confronted with the challenge of selecting the
most appropriate treatment strategy in the absence of empirically derived procedures to
match a particular patient’s drug abuse history and personal characteristics to the treatment
method most likely to be successful for that person. As a result, treatment programs are
broadly ranged and usually multifaceted in an attempt to cope with the complexity of
the disorder. Treatment is offered in a wide variety of settings including residential and
outpatient units, with diverse expected frequency and duration of clinical contact, in
both group and individual format, providing professionals with diverse levels of experience,
and training (e.g., psychiatrist, psychologist, social workers, and counselors), with or
without pharmacotherapy support, varying in the specific content and approach of
psychosocial therapy offered and in the number and types of ancillary services (e.g.,
medical, psychiatric, psychological, occupational, vocational) available to patients (National
Institute on Drug Abuse, 1999).
It is within this context diversity that everyday services struggle with treatment
difficulties seeing that successful treatment depends in part on the amount of time spent
in the treatment program. Six to twelve months of treatment are often needed, as those
who remain in a program for one year are less likely to return to regular drug use than
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those in treatment less than one year (Hubbard et al., 1989). Improving the quality of
treatment is an endeavor that not only involves the search for new and more effective
treatments, but also continuing reshaping and monitoring of treatment delivery.
Undoubtedly, treatment enhancement requires a substantial effort across many contexts:
the scientific community, society, public officials, treatment programs, health professional,
and the patients themselves (Zanis, McLellan, Belding, and Moyer, 1997).
Potthoff (1995) has provided a conceptualization of the consumer characteristics
that are central to an understanding of the outcomes of substance abuse treatment for
managed care providers. This approach is broad and includes, social functioning with
family and friends, participation in community activities and hobbies, employment
status, perceived health status, recent and past history of substance use, psychiatric
comorbidity, etc. Recent research showed that individual characteristics, rather than the
drug, play a dominant role in vulnerability to drug abuse. The social and psychological
maladjustment frequently precedes the first drug use (Glantz, 1992). A study that tracked
children from an early age to adulthood identified predictors of future serious drug use
that could be identified in children’s behavior as early as age seven (Shedler and Block,
1990). Although initial low-level involvement with drugs may result from peer pressure,
drug availability or other risk factors in an individual’s social or family environment.
Subsequent escalation to and maintenance of higher levels of drug use is likely to result
from biological, psychological or psychiatric characteristics of the individual user.
From the present descriptive study using questionnaires (Montero and León, 2005;
Ramos-Álvarez, Valdés-Conroy, and Catena, 2006), we try to explore and highlight
some key characteristics of individuals with a drug addiction when starting a treatment
program. The purpose is to recognize the biopsychosocial factors that the patients bring
to therapy and that will be of importance for treatment efficacy over time.
Method
Participants
A total of 107 participants of an Addiction Treatment Center consented to participate
in the study, most of them were Portuguese (97.2%), 90.7% were male and 9.3%
female, with age ranging between 22 and 55 years (M = 34.84, SD = 6.44). Among the
107 patients, 29.9% were referred to this service by their family and/or friends, 15%
by self-initiative, and 10.3% by hospitals and/or health service. Most had the basic
educational level: 42.5% completed grammar school, 29.2% finished high school. Most
were single (42.5%), 37.7% married or living together, and 18.9% separated or divorced.
A substantial number (35.8%) were still living with their parents, 17.9% with a partner
and children, and 15.1% alone. The majority (76.4%) were unemployed or looking for
a job.
Most (81.1%) used drugs daily, and in 62.4% of the cases heroin was the drug of
choice, in 30.1% of the cases in association with cocaine. Most patients (53.8%) smoked
and/or inhaled it contrasting with the 33% who choose to inject themselves. The majority
of participants (61.7%) had been involved in previous treatment programs; the interval
since the last treatment ranged between 6 month and 15 years (M = 3.93, SD = 4.18).
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Cannabis was the first drug used by 82% of participants. Age of first contact with drugs
ranged between 11 and 36 years (M = 16.69, SD = 4.66), and the mean age of drug
consumption was 20.12 years (SD = 5.11, amplitude: 13-36 years).
Instruments
– The Drug Abuse Screening Test (DAST) (Skinner, 1982) is a general measure
of drug abuse. The DAST yields a quantitative index of drug problems, including
some drug dependence symptoms and other consequences resulting from the
abuse of psychoactive drugs (not including alcohol) experienced over a 12-
month period. This instrument was based on the Michigan Alcoholism Screening
Test (MAST) (Selzer, 1971). It was developed as a brief measure of the severity
of drug involvement for both clinical case finding during assessment and use in
treatment evaluation research. The DAST consist of 20 items that assess some
features of drug dependence syndrome (inability to stop using drugs, inability
to get through a week without drugs, and withdrawal symptoms with cessation
of drug use) and other consequences related to the use or abuse of prescribed,
over-the-counter and illicit drugs. Respondents indicate whether they have
experienced each drug-related problem in the past 12 months. Good validity and
reliability values have been reported for the DAST (Cocco and Carey, 1998;
Skinner, 1982; Skinner and Goldberg, 1986). The results of the Portuguese
study revealed also acceptable reliability values (α = .74) (Machado and Klein,
2006a).
– The Outcome Questionnaire (OQ-45.2) (Lambert, Hansen et al., 1996) is a brief
self-report instrument, designed for repeated measurement of client status through
the course of therapy and at termination. Ease of administration and scoring,
low cost, sensitivity to changes in psychological distress over short periods of
time, and an ability to assess a wide array of symptomatology and role functioning
may make this instrument useful in a variety of clinical and counseling applications.
The OQ was formulated according to Lambert’s (1983) organizational scheme
for outcome assessment, suggesting that three dimensions or content areas (called
domains) be evaluated: intrapersonal (subjective) discomfort or symptomatic
distress, interpersonal functioning, and social role performance. Due to the high
inter-correlations between subscales, the total score is recommended for assessment
of outcome. Three-week test-retest reliability for OQ is .84; internal consistency
is .93; and correlations with similar measures range from .53 to .88 (Lambert,
Burlingame et al., 1996). The Portuguese study of this scale showed similar
values then the original, namely, a internal consistency of .90 (Machado and
Klein, 2006b).
Procedure
Participants were evaluated prior to admission, in their first contact with the treatment
center, in which they manifest the intention of undergoing a treatment program. After
signing the consent form a member of the research team supervised the application of
the two measures. Participants who showed mental deterioration, inability to read the
instructions or were agitated were excluded from the study.
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Results
Table 1 shows the DAST and OQ-45 total scores and its subscales. Participants
were characterized by an elevated mean DAST score (M = 12.41, SD = 3.60) which
indicates the presence of significant severity in drug consumption. The mean OQ-45
total score is 82.55 which fall within a range of moderate severity in terms of functional
impairment. The symptom distress scale presents a moderate impairment score (M =
47.36, SD = 17.78), as the interpersonal relationship and social role have mild impairment
of functioning scores, respectively 20 (SD = 7.37) and 15.19 (SD = 5.57). Participants
that had been previously involved in treatment showed a higher DAST score (M =
13.09, SD = 3.32; t(105) = 2.53, p = .013) than those who had never been involved in
a treatment program (M = 11.31, SD = 3.80).
TABLE 1. Descriptive statistics of severity and functioning scores.
Table 2 shows the correlations between OQ-45 and DAST scores. All correlations
are medium or strong. We verified that the symptom distress scale has a very strong
positive correlation (r = .97, p < .01) with the OQ-45 total score and with the interpersonal
relationship scale (r = .81, p < .01), and less strong with the social role scale (r = .55,
p < .01) and the DAST (r = .50, p < .01). Moreover, there were medium positive
correlations between the DAST and the OQ-45 and its subscales, with high levels of
drug severity associated with poorer performance in social role, interpersonal relationships
and more distress.
TABLE 2. Correlations between DAST and OQ-45 scales (N = 107).
Notes. All coefficients significant p < .01; OQ-sd: symptom
distress; OQ-if: interpersonal functioning; OQ-sr: social role.
Scale M SD min. max.
DAST 12.41 3.60 2 19
OQ-45 Total 82.55 27.66 6 142
OQ-45 Symptom distress 47.36 17.78 3 87
OQ-45 Interpersonal functioning 20 7.37 0 36
OQ-45 Social role 15.19 5.57 3 26
DAST OQ-sd OQ-if OQ-sr
DAST --
OQ-sd .50 --
OQ-if .43 .81 --
OQ-sr .42 .55 .52 --
OQ-total .52 .97 .89 .69
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Discussion
Results of this preliminary study show that patients attending the drug treatment
centre are characterized by significant severity of drug consumption and related problems.
Additionally, they present significant psychological distress that is strongly correlated
with the severity of the drug addiction. There are several limitations to this study. First,
the data were based on self-report measures and their possible biases (e.g., Stacy,
Widaman, Hays, and DiMatteo, 1985). Others have noted that self-report measures of
drug use are valid and have provided empirical tests to underscore these claims (e.g.,
Needle, Jou, and Su, 1989). Although, error in measurement could be decreased through
use of collateral and independent reports of drug use, this information was not available
for these data.
Second, we did not assess psychiatric impairment with standard clinical diagnostic
criteria (i.e., American Psychiatric Association, 2000). Instead, we used standard and
proven epidemiological assessment tools that have demonstrated validity and reliability
in general community studies. Even though standard diagnostic assessment is most
appropriate with clinical populations; these categorical decision criteria are less appropriate
and useful with community samples. Moreover, they are dichotomous and therefore do
not capture the true range of psychopathology that is subclinical in extent. In view of
that, the measures in this study provided a broad, but still limited, assessment of
psychopathology, as well as capturing the full range of disturbance in each type of
psychopathology. In future research, we will strengthen the effects observed between
drug use and psychopathology, using therefore a wider selection of assessment tools,
clinical and treatment data.
Finally, data of both men and women were analyzed together. Like other studies
(e.g., Johnston, O’Malley, and Bachman, 1988), characteristics of drug use may differ
between sexes, although we did not conduct analyses separately by sex because it
would produce too small samples (especially the female sample) and compromising the
robustness of statistical analyses. However, due to the lack of clinical data on severe
drug addiction in Portugal, we think that this study might shed some light on such a
complicated psychological and social phenomenon.
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